IP Library Patent Application 10514054
Patent Application
App. No. 10/514,054

Brachyspira hyodysenteriae vaccine

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/514,054
Abstract

The present invention relates to nucleic acid sequences encoding a 30 kD Brachyspira hyodysenteriae lipoprotein and to parts of such nucleic acid sequences that encode an immunogenic fragment of such lipoproteins, and to DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof. The invention also relates to a 30 kD Brachyspira hyodysenteriae lipoprotein and immunogenic parts thereof encoded by such sequences. Furthermore, the present invention relates to vaccines comprising such nucleic acid sequences and parts thereof, DNA fragments, recombinant DNA molecules, live recombinant carriers and host. Cells comprising such nucleic acid sequences or such parts thereof, lipoproteins or immunogenic parts thereof and antibodies against such lipoproteins or immunogenic parts thereof. Also, the invention relates to the use of said lipoproteins in vaccines and for the manufacture of vaccines. Moreover, the invention relates to the use of said nucleic acid sequences, lipoproteins or antibodies for diagnostic or vaccination purposes. Finally the invention relates to diagnostic kits comprising such a nucleic acid, lipoprotein or antibodies against such lipoprotein.

Claims (28)

1 . A nucleic acid sequence encoding a 30 kD Brachyspira hyodysenteriae lipoprotein, comprising:

a nucleic acid sequence of one of the paralogous Brachyspira hyodysenteriae lipoprotein genes as depicted in SEQ ID NO: 1.

2 . (canceled)

3 . A DNA fragment, comprising:

the nucleic acid sequence according to claim 1 .

4 . A recombinant DNA molecule, comprising:

the nucleic acid sequence according to claim 1 , under the control of a functionally linked promoter.

5 . A live recombinant carrier, comprising:

the nucleic acid sequence according to claim 1 .

6 . A host cell, comprising:

the nucleic acid sequence according to claim 1 .

7 . An 30 kD Brachyspira hyodysenteriae lipoprotein having an amino acid sequence as depicted in SEQ ID NO: 2, 3, 4 or 5.

8 . (canceled)

9 . An 30 kD Brachyspira hyodysenteriae lipoprotein, wherein it is encoded by a nucleic acid sequence according to claim 1 .

10 . (canceled)

11 . (canceled)

12 . (canceled)

13 . (canceled)

14 . (canceled)

15 . (canceled)

16 . (canceled)

17 . (canceled)

18 . A diagnostic kit, comprising:

suitable detection means and

a nucleic acid sequence according to claim 1 .

19 . A pharmaceutical composition, comprising:

the nucleic acid sequence according to claim 1 and

a pharmaceutically acceptable carrier.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2006
From: AKZO NOBEL N.V.
To: INTERVET INTERNATIONAL B.V.
Reel/Frame 018490/0365 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2005
From: ADLER, BEN; CULLEN, PAUL ANTONY; COUTTS, SCOTT ADAM JAMES; BULACH, DIETER MARK; SEGERS, RUUD PHILIP A. M.
To: AKZO NOBEL N.V.
Reel/Frame 016014/0255 →